There are more than 81,000 new cases of bladder cancer each year. Most diagnoses occur after the age of 55 and the average age at diagnosis is 73. Bladder cancer is often found in the early stages due to early symptoms, which helps increase the likelihood of successful treatment. The most common symptom for bladder cancer patients is blood in the urine, but other symptoms that may be experienced are back/abdominal pain, pain during urination, and urinating frequently. The 5-year survival rate for bladder cancer is 77%, which is more favorable than other cancer types. To increase this, ongoing clinical research is aimed at improving the care for bladder cancer patients.
Common treatments for bladder cancer patients include surgery and chemotherapy. Clinical trials also offer new therapies for bladder cancer. Navigating which clinical trial is right for you can be a long and overwhelming process. Each individual is different, so it is important to speak with a doctor to see if clinical trials can benefit you. With 277 trials currently available, a tool like Massive Bio’s Clinical Trial Matching Service (CTMS) can find personalized matches for bladder cancer patients. The CTMS is equipped with an Artificial-Intelligence based platform with custom clinical algorithms that identify the trials near you that can be the most beneficial for your specific cancer case.